North America And Europe Phototherapy Treatment Market

Phototherapy Treatment Market for Acne and Psoriasis: Blue Light Phototherapy Projected to be the Most Lucrative Segment During the Forecast Period: North America and Europe Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

Family physicians are playing a crucial role in diagnosing psoriasis in Canada

In Canada, the majority of the psoriasis patients are mainly diagnosed by family physicians rather than by dermatologists. The reason behind this is the lack of dermatologists and related services in Canada. For instance, according to a report published by the Economist Intelligence Unit, Canada had less than 2 dermatologists per 100,000 individuals in 2015, which is very less when compared with European countries. It has also been observed that family physicians typically prefer topical therapies than biologics/phototherapy to treat psoriasis conditions, while dermatologists prefer phototherapy more than the other available therapies/medications. This recent trend is boosting the phototherapy segment. While in the U.S. the growing population of adult women suffering from acne and psoriasis is an important factor driving revenue growth of the phototherapy segment. The population of adult women is rising with higher rates in North America than in European countries such as Germany, Italy, France and Spain. The growth in women adult acne conditions in North America is mainly due to increase in male hormonal (androgens) levels in females.

Complementary therapies to treat psoriasis conditions and combination therapies are recent trends in Western Europe, which are creating a positive impact on the phototherapy segment in the regional market

Complementary therapies such as balneotherapy along with UV radiation is quite popular in Western European countries. Balneotherapy is the oldest treatment method available to treat the psoriasis condition. In this treatment, the patient undergoes a bath in high mineralized brine, which causes a mechanical removal of skin scales and increases the sensitivity of skin to UV radiation. Combination therapies are set to witness high potential in austerity driven markets in Europe as noted by many clinic managers. Faltering out-of-pocket expenses for a service that is considered as a desire or luxury coupled with a tricky pricing of combination treatments involving a device and a drug are factors successfully helping in generating revenue in the market. This trend is very prominent in countries such as the U.K. and Spain.

north america and europe phototherapy treatment market

Approved by the FDA to treat acne and psoriasis, blue light therapy dominates the North America and Europe phototherapy treatment market

By phototherapy type, blue light therapy dominated the North America and Europe phototherapy treatment market for psoriasis and acne, and is expected to be the most lucrative segment over the forecast period, with a market attractiveness index of 3.3. By the end of 2027, the blue light phototherapy segment is projected to reach more than US$ 1,000 Mn, expanding at a CAGR of 6.7% over the forecast period. Revenue from the Narrowband UVB phototherapy segment in the North America and Europe phototherapy treatment market for psoriasis and acne is expected to grow 1.9x by 2027 end as compared to that in 2017. The Red Light Phototherapy and Intense Pulsed Light (IPL) Phototherapy segments represent the lowest market attractiveness index of 0.3 each.

Availability of various treatments for acne and psoriasis and declining reimbursement rates are expected to hamper the growth of the phototherapy segment

Various treatments are currently available in the market to treat acne and psoriasis conditions. For instance, to treat acne conditions various drugs are available in the market such as topical/oral antibiotics and retinoid and chemical peels, among others. Due to a lot of available treatment options, physicians prescribe different treatments according to the patient’s skin nature and availability of drugs. Owing to the many treatment options, very few physicians prescribe phototherapy to patients. Furthermore, availability of non-office based treatments to treat acne and psoriasis conditions has a negative impact on the growth of the phototherapy segment. Furthermore, the decline of reimbursement pay and lack of adequate phototherapy units in the market are projected to hamper revenue growth of the phototherapy segment over the forecast period.

The opportunity analysis covered to understand the North America and Europe phototherapy treatment market for acne and psoriasis, makes this new publication an exclusive one. After a thorough study of the market, our expert team of analysts in the healthcare domain went the extra mile to offer in-depth insights into the market. While studying the market the first important feature we have observed is that this market is likely to witness moderate growth during the 10 year projected period. After a detailed study of the future scenario of the overall market, it was easy for our analysts to identify the macroeconomic factors such as the economic burden of skin diseases and societal habits influencing the phototherapy treatment market for acne and psoriasis in North America and Europe. The report titled “Phototherapy Treatment Market for Acne and Psoriasis: North America and Europe Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027” provides detailed information on how the lack of robust clinical evidence on various disease conditions is limiting the growth of the phototherapy treatment market for acne and psoriasis in the regions of North America and Europe.

One astonishing fact we have come across while inspecting this market is that even in the most developed regions such as North America and Europe, not much research has been done on the other light therapies used in the treatment of acne and psoriasis conditions except blue light and UVB therapy. On the other hand while covering the disease epidemiology we have observed that prevalent cases of acne and psoriasis were remarkable in both the regions especially Europe in 2015.

Is the home-based phototherapy system a solution to limit the rising incidents of the disease?

Usually, phototherapy is an office based treatment procedure. However, lack of sufficient phototherapy units and the majority of phototherapy centres being located in urban areas are forcing patients to choose alternative treatments for their dermatological conditions. An increasing adoption of home-based phototherapy systems is creating huge opportunities for manufacturers. Home based phototherapy reduces patient hassles like transportation issues and the long waiting time in clinics, among others. In addition to this, it also reduces the direct and indirect medical costs of patients.

Our unique analysis of the classification of markets in various segments

According to our analysis, North America represents the most lucrative market, followed by Western Europe and Eastern Europe.

  • Hospitals end user segment dominates the global market; however, home care settings are becoming the choice of service for patients
  • Blue light therapy is gaining more traction in phototherapy owing to its benefits in treating acne
  • Plaque psoriasis sub-segment dominates the market in the psoriasis disease segment due to rise in psoriasis patient population

International monoclonal antibody conference reports – our key source while researching this market

While inspecting the North America and Europe phototherapy treatment market for acne and psoriasis in detail, we have referred to the annual reports, publications, and presentations of product providers. Our analysts have also considered key winning strategies followed by phototherapy treatment market for acne and psoriasis product manufacturers. We have carried out systematic and exhaustive secondary research to analyse the required data points to arrive at the overall market numbers. Detailed questionnaires have been developed for each node in the value chain to extract the required market information through primary research interviews. Data acquired through research is represented using charts, infographics, presentation of key findings by region and providing strategic recommendations and actionable insights for critical decision making.

North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy

By Disease Type

By Phototherapy Type

By End User

By Region

  • Psoriasis

    • Guttate Psoriasis

    • Inverse Psoriasis

    • Pustular Psoriasis

    • Erythrodermic Psoriasis

    • Plaque Psoriasis

  • Acne

    • Acne Vulgaris

    • Acne Conglobata

    • Acne Fulminans

    • Gram-Negative Folliculitis

    • Acne Rosacea

    • Pyoderma Faciale

  • Blue Light Phototherapy

  • Red Light Phototherapy

  • Intense Pulsed Light (IPL) Phototherapy

  • Narrowband UVB Phototherapy

  • Psoralens+Ultravioletlight A (PUVA) Phototherapy

  • Hospitals

  • Dermatology Clinics/Skin Care Centres

  • Wellness Centres

  • Home Care Settings

  • North America

  • Western Europe

  • Eastern Europe

North America And Europe Phototherapy Treatment Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

2.3. Phototherapy Treatment Market Overview

3. Medical Bionic Implants & Exoskeletons Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Pricing Assumptions

4. North America Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

4.3.1. U.S.

4.3.2. Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1. U.S.

4.4.2. Canada

4.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

4.5.1. Psoriasis

4.5.1.1. Guttate Psoriasis

4.5.1.2. Inverse Psoriasis

4.5.1.3. Pustular Psoriasis

4.5.1.4. Erythrodermic Psoriasis

4.5.1.5. Plaque Psoriasis

4.5.2. Acne

4.5.2.1. Acne Vulgaris

4.5.2.2. Acne Conglobata

4.5.2.3. Acne Fulminans

4.5.2.4. Gram-Negative Folliculitis

4.5.2.5. Acne Rosacea

4.5.2.6. Pyoderma Faciale

4.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

4.6.1. Psoriasis

4.6.1.1. Guttate Psoriasis

4.6.1.2. Inverse Psoriasis

4.6.1.3. Pustular Psoriasis

4.6.1.4. Erythrodermic Psoriasis

4.6.1.5. Plaque Psoriasis

4.6.2. Acne

4.6.2.1. Acne Vulgaris

4.6.2.2. Acne Conglobata

4.6.2.3. Acne Fulminans

4.6.2.4. Gram-Negative Folliculitis

4.6.2.5. Acne Rosacea

4.6.2.6. Pyoderma Faciale

4.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

4.7.1. Blue Light Phototherapy

4.7.2. Red Light Phototherapy

4.7.3. Intense Pulsed Light (IPL) Phototherapy

4.7.4. Combination Treatment

4.7.5. Narrowband UVB Phototherapy

4.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

4.7.7. Others

4.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

4.8.1. Blue Light Phototherapy

4.8.2. Red Light Phototherapy

4.8.3. Intense Pulsed Light (IPL) Phototherapy

4.8.4. Combination Treatment

4.8.5. Narrowband UVB Phototherapy

4.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

4.8.7. Others

4.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

4.9.1. Hospitals

4.9.2. Dermatology Clinics/Skin Care Centers

4.9.3. Wellness Centers

4.9.4. Home Care Settings 

4.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

4.10.1. Hospitals

4.10.2. Dermatology Clinics/Skin Care Centers

4.10.3. Wellness Centers

4.10.4. Home Care Settings

4.11.Market Attractiveness Analysis

4.11.1. By Country

4.11.2. By Disease Type

4.11.3. By Phototherapy

4.11.4. By End User

5. Western Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027 

5.1. Introduction

5.2. Regional Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Trends

5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

5.3.1. Germany

5.3.2. United Kingdom

5.3.3. France

5.3.4. Italy

5.3.5. Spain

5.3.6. Nordics

5.3.7. BENELUX

5.3.8. Rest of Western Europe

5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

5.4.1. Germany

5.4.2. United Kingdom

5.4.3. France

5.4.4. Italy

5.4.5. Spain

5.4.6. Nordics

5.4.7. BENELUX

5.4.8. Rest of Western Europe

5.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

5.5.1. Psoriasis

5.5.1.1. Guttate Psoriasis

5.5.1.2. Inverse Psoriasis

5.5.1.3. Pustular Psoriasis

5.5.1.4. Erythrodermic Psoriasis

5.5.1.5. Plaque Psoriasis

5.5.2. Acne

5.5.2.1. Acne Vulgaris

5.5.2.2. Acne Conglobata

5.5.2.3. Acne Fulminans

5.5.2.4. Gram-Negative Folliculitis

5.5.2.5. Acne Rosacea

5.5.2.6. Pyoderma Faciale

5.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

5.6.1. Psoriasis

5.6.1.1. Guttate Psoriasis

5.6.1.2. Inverse Psoriasis

5.6.1.3. Pustular Psoriasis

5.6.1.4. Erythrodermic Psoriasis

5.6.1.5. Plaque Psoriasis

5.6.2. Acne

5.6.2.1. Acne Vulgaris

5.6.2.2. Acne Conglobata

5.6.2.3. Acne Fulminans

5.6.2.4. Gram-Negative Folliculitis

5.6.2.5. Acne Rosacea

5.6.2.6. Pyoderma Faciale

5.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

5.7.1. Blue Light Phototherapy

5.7.2. Red Light Phototherapy

5.7.3. Intense Pulsed Light (IPL) Phototherapy

5.7.4. Combination Treatment

5.7.5. Narrowband UVB Phototherapy

5.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

5.7.7. Others

5.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

5.8.1. Blue Light Phototherapy

5.8.2. Red Light Phototherapy

5.8.3. Intense Pulsed Light (IPL) Phototherapy

5.8.4. Combination Treatment

5.8.5. Narrowband UVB Phototherapy

5.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

5.8.7. Others

5.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

5.9.1. Hospitals

5.9.2. Dermatology Clinics/Skin Care Centers

5.9.3. Wellness Centers

5.9.4. Home Care Settings 

5.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

5.10.1. Hospitals

5.10.2. Dermatology Clinics/Skin Care Centers

5.10.3. Wellness Centers

5.10.4. Home Care Settings

5.11.Market Attractiveness Analysis

5.11.1. By Country

5.11.2. By Disease Type

5.11.3. By Phototherapy

5.11.4. By End User

6. Eastern Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Regional Market Dynamics

6.2.1. Drivers

6.2.2. Restraints

6.2.3. Trends

6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

6.3.1. Russia

6.3.2. Poland

6.3.3. Rest of Eastern Europe

6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

6.4.1. Russia

6.4.2. Poland

6.4.3. Rest of Eastern Europe

6.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

6.5.1. Psoriasis

6.5.1.1. Guttate Psoriasis

6.5.1.2. Inverse Psoriasis

6.5.1.3. Pustular Psoriasis

6.5.1.4. Erythrodermic Psoriasis

6.5.1.5. Plaque Psoriasis

6.5.2. Acne

6.5.2.1. Acne Vulgaris

6.5.2.2. Acne Conglobata

6.5.2.3. Acne Fulminans

6.5.2.4. Gram-Negative Folliculitis

6.5.2.5. Acne Rosacea

6.5.2.6. Pyoderma Faciale

6.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

6.6.1. Psoriasis

6.6.1.1. Guttate Psoriasis

6.6.1.2. Inverse Psoriasis

6.6.1.3. Pustular Psoriasis

6.6.1.4. Erythrodermic Psoriasis

6.6.1.5. Plaque Psoriasis

6.6.2. Acne

6.6.2.1. Acne Vulgaris

6.6.2.2. Acne Conglobata

6.6.2.3. Acne Fulminans

6.6.2.4. Gram-Negative Folliculitis

6.6.2.5. Acne Rosacea

6.6.2.6. Pyoderma Faciale

6.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

6.7.1. Blue Light Phototherapy

6.7.2. Red Light Phototherapy

6.7.3. Intense Pulsed Light (IPL) Phototherapy

6.7.4. Combination Treatment

6.7.5. Narrowband UVB Phototherapy

6.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

6.7.7. Others

6.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

6.8.1. Blue Light Phototherapy

6.8.2. Red Light Phototherapy

6.8.3. Intense Pulsed Light (IPL) Phototherapy

6.8.4. Combination Treatment

6.8.5. Narrowband UVB Phototherapy

6.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

6.8.7. Others

6.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

6.9.1. Hospitals

6.9.2. Dermatology Clinics/Skin Care Centers

6.9.3. Wellness Centers

6.9.4. Home Care Settings 

6.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

6.10.1. Hospitals

6.10.2. Dermatology Clinics/Skin Care Centers

6.10.3. Wellness Centers

6.10.4. Home Care Settings

6.11.Market Attractiveness Analysis

6.11.1. By Country

6.11.2. By Disease Type

6.11.3. By Phototherapy

6.11.4. By End User

7. Forecast Factors: Relevance and Impact

8. Forecast Assumptions

9. Competition Landscape

9.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

9.1.1. Lifespan

9.1.2. UC Irvine Health

9.1.3. Buffalo Medical Group

9.1.4. Blackrock Clinic Limited

9.1.5. The Private Phototherapy Clinic Ltd

9.1.6. National Skin Centre

9.1.7. Massachusetts General Hospital

10. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Region

10.1.Historical Market Size (US$ Mn) Analysis By Region, 2012-2016

10.1.1. North America

10.1.2. Western Europe

10.1.3. Eastern Europe

10.2.Market Size (US$ Mn) Forecast By Region, 2017-2027

10.2.1. North America

10.2.2. Western Europe

10.2.3. Eastern Europe

10.3.Market Attractiveness Analysis By Region

11. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Disease

11.1.Introduction/Key Finding

11.2.Historical Market Size (US$ Mn) Analysis By Disease, 2012-2016

11.2.1. Psoriasis

11.2.1.1. Guttate Psoriasis

11.2.1.2. Inverse Psoriasis

11.2.1.3. Pustular Psoriasis

11.2.1.4. Erythrodermic Psoriasis

11.2.1.5. Plaque Psoriasis

11.2.2. Acne

11.2.2.1. Acne Vulgaris

11.2.2.2. Acne Conglobata

11.2.2.3. Acne Fulminans

11.2.2.4. Gram-Negative Folliculitis

11.2.2.5. Acne Rosacea

11.2.2.6. Pyoderma Faciale

11.3.Market Size (US$ Mn) Forecast By Disease, 2017-2027

11.3.1. Psoriasis

11.3.1.1. Guttate Psoriasis

11.3.1.2. Inverse Psoriasis

11.3.1.3. Pustular Psoriasis

11.3.1.4. Erythrodermic Psoriasis

11.3.1.5. Plaque Psoriasis

11.3.2. Acne

11.3.2.1. Acne Vulgaris

11.3.2.2. Acne Conglobata

11.3.2.3. Acne Fulminans

11.3.2.4. Gram-Negative Folliculitis

11.3.2.5. Acne Rosacea

11.3.2.6. Pyoderma Faciale

11.4.Market Attractiveness Analysis By Disease

12. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Phototherapy 

12.1.Introduction/Key Finding

12.2.Historical Market Size (US$ Mn) Analysis By Mode, 2012-2016

12.2.1. Blue Light Phototherapy

12.2.2. Red Light Phototherapy

12.2.3. Intense Pulsed Light (IPL) Phototherapy

12.2.4. Combination Treatment

12.2.5. Narrowband UVB Phototherapy

12.2.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

12.2.7. Others

12.3.Market Size (US$ Mn) Forecast By Mode, 2017-2027

12.3.1. Blue Light Phototherapy

12.3.2. Red Light Phototherapy

12.3.3. Intense Pulsed Light (IPL) Phototherapy

12.3.4. Combination Treatment

12.3.5. Narrowband UVB Phototherapy

12.3.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

12.3.7. Others

12.4.Market Attractiveness Analysis By Phototherapy

13. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By End User 

13.1.Introduction/Key Finding

13.2.Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

13.2.1. Hospitals

13.2.2. Dermatology Clinics/Skin Care Centers

13.2.3. Wellness Centers

13.2.4. Home Care Settings 

13.3.Market Size (US$ Mn) Forecast By End User, 2017-2027

13.3.1. Hospitals

13.3.2. Dermatology Clinics/Skin Care Centers

13.3.3. Wellness Centers

13.3.4. Home Care Settings 

13.4.Market Attractiveness Analysis By End User

14. Assumptions and Acronyms Used

15. Research Methodology

North America And Europe Phototherapy Treatment Market Reports - List of Tables

Table 1: North America Phototherapy Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 2: North America Phototherapy Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 3: North America Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 4: North America Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 5: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 6: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 7: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 8: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 9: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 10: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 11: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 12: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 13: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region

Table 14: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease

Table 15: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 16: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

North America And Europe Phototherapy Treatment Market Reports - List of Figures

Figure 1: North America and Europe Phototherapy Market Value Analysis and Forecast, 2017–2027 (US$ Mn)

Figure 2: North America Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027 

Figure 3: North America Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027 

Figure 4: North America Phototherapy Treatment Market Size Analysis (%) 2012–2016

Figure 5: North America Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027

Figure 6: North America Phototherapy Treatment Market Attractiveness Analysis, By Country

Figure 7: North America Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy

Figure 8: North America Phototherapy Treatment Market Attractiveness Analysis, By Disease Type

Figure 9: North America Phototherapy Treatment Market Attractiveness Analysis, By End User

Figure 10: Western Europe Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027 

Figure 11: Western Europe Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027 

Figure 12: Western Europe Phototherapy Treatment Market Size Analysis (%), 2012–2016

Figure 13: Western Europe Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027

Figure 14: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Country

Figure 15: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy

Figure 16: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Disease Type

Figure 17: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By End User

Figure 18: Acne and Psoriasis Prevalence Rates in Eastern Europe Region, 2015

Figure 19: Psoriasis Patients in Eastern Europe Region, 2010 & 2015

Figure 20: Eastern Europe Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027 

Figure 21: Eastern Europe Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027 

Figure 22: Eastern Europe Phototherapy Treatment Market Size Analysis (%), 2012–2016

Figure 23: Eastern Europe Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027

Figure 24: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Country

Figure 25: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy 

Figure 26: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Disease Type

Figure 27: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By End User

Figure 28: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By Region

Figure 29: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, Disease

Figure 30: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy

Figure 31: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By End User